RT Book, Section
A1 Widerman, Meagan
A1 Pratte, Michael
SR Print(0)
ID 1184669908
T1 Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo
T2 2 Minute Medicine
YR 2015
FD 2015
PB McGraw Hill
PP New York, NY
SN 
LK accesssurgery.mhmedical.com/updatesContent.aspx?gbosid=569957
RD 2024/04/18
AB